These results suggest that overexpression of EHD2 in tumor cells is associated with the occurrence of dyscohesive cells in the tumor periphery and invasive front of PTC with roles in tumor progression through activating MAPK signaling pathway. This evidence concerns the gene EHD2 and neoplasm.